Discover
HNGE
Hinge Health, Inc.
85.07
600 x undefined
100 x undefined
bid
ask
+
2.07
2.49%
350 @ 06:09 AM
85.00 -0.07 (0.08%)
| Ytd | 83.14% | |
| 1y | 87.75% |
81.72
day range
86.66
30.08
52 week range
86.66
| Open | 83.58 | Prev Close | 83.00 | Low | 81.72 | High | 86.66 | Mkt Cap | 6.58B |
| Vol | 1.84M | Avg Vol | 1.72M | EPS | -8.92 | P/E | N/A | Forward P/E | 24.56 |
| Beta | N/A | Short Ratio | 3.40 | Inst. Own | 108.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 58.77 | 200-d Avg | 48.63 | 1yr Est | 82.07 |
| Income Statement | |||
| Total Revenue | 182.31M | ||
| Revenues (USD) | 182.31M | ||
| Cost of Revenue | 28.07M | ||
| Gross Profit | 154.23M | ||
| Operating Expenses | 122.16M | ||
| Research and Development Expense | 30.34M | ||
| Selling, General and Administrative Expense | 91.83M | ||
| Operating Income | 32.07M | ||
| Income Tax Expense | 814.00K | ||
| Net Income | 35.13M | ||
| Net Income Common Stock | 34.01M | ||
| Net Income Common Stock (USD) | 34.01M | ||
| Consolidated Income | 35.13M | ||
| Earnings per Basic Share | 0.43 | ||
| Earnings per Basic Share (USD) | 0.43 | ||
| Earnings per Diluted Share | 0.41 | ||
| Earning Before Interest & Taxes (EBIT) | 35.94M | ||
| Earning Before Interest & Taxes (USD) | 35.94M | ||
| Preferred Dividends Income Statement Impact | 1.12M | ||
| Weighted Average Shares | 78.62M | ||
| Weighted Average Shares Diluted | 82.39M | ||
| Balance Sheet | |||
| Cash and Equivalents | 186.67M | ||
| Cash and Equivalents (USD) | 186.67M | ||
| Investments | 218.97M | ||
| Investments Current | 129.20M | ||
| Investments Non-Current | 89.77M | ||
| Trade and Non-Trade Receivables | 114.92M | ||
| Current Assets | 540.05M | ||
| Property, Plant & Equipment Net | 17.31M | ||
| Total Assets | 728.77M | ||
| Debt Current | 4.23M | ||
| Total Debt | 6.97M | ||
| Current Liabilities | 414.48M | ||
| Debt Non-Current | 2.74M | ||
| Total Liabilities | 417.21M | ||
| Accumulated Retained Earnings (Deficit) | -1.02B | ||
| Accumulated Other Comprehensive Income | -348.00K | ||
| Shareholders Equity | 111.69M | ||
| Shareholders Equity (USD) | 111.69M | ||
| Assets Non-Current | 188.72M | ||
| Total Debt (USD) | 6.97M | ||
| Deferred Revenue | 340.77M | ||
| Goodwill and Intangible Assets | 66.38M | ||
| Inventory | 14.17M | ||
| Liabilities Non-Current | 2.74M | ||
| Trade and Non-Trade Payables | 69.48M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.08M | ||
| Net Cash Flow from Financing | -112.85M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -21.68M | ||
| Capital Expenditure | -1.53M | ||
| Issuance (Purchase) of Equity Shares | -104.56M | ||
| Net Cash Flow from Investing | 48.08M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 49.61M | ||
| Net Cash Flow from Operations | 43.08M | ||
| Share Based Compensation | 11.69M | ||